Stock Ratings / Consumer Discretionary / MRM / options

OCG (53) PMAX (57) EJH (33) JWEL (50) ⌘ Pro Terminal →

MEDIROM Healthcare Technologies Inc. (MRM) Options Positioning, Max Pain & Unusual Sweeps

Q: What is MRM's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for MRM.

$0.35 -3.24% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

MEDIROM Healthcare Technologies Inc. (MRM) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $2.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE+0% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MRM)Realized 20D OHLCV Swing Band: ±12.5%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±12.5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (MRM)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for MRM.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MRM)

✓Walkthrough of MRM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MRM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -69.83%▼ DESCENDING CHANNEL

2026-10-30O $0.34H $0.35L $0.33C $0.35VOL 19.1K

RES: $0.90SUP: $0.13SMA50: $0.66SMA200: $1.05

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MRM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MRM Butterfly Map → + Track MRM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MRM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MRM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MRM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MRM)

Consumer Discretionary Rank #528 of 1011 ⚔️ OCG vs MRM Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (MRM vs. OCG, PMAX, EJH, JWEL)

Industry: Other Consumer Services (73 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, MEDIROM Healthcare Technologies Inc. (MRM) ranks #528 by composite RQD confidence (56/100, grade D+) and #988 by equity capitalization ($2.7M). Within this direct 5-issuer industry benchmark cohort, MRM leads on earnings valuation at N/A trailing P/E, while OCG leads on capital efficiency and profitability with -9.4% ROIC and 85.7% gross margin. PMAX currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with MRM at 56/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MRM ACTIVE MEDIROM Healthcare Technologies Inc.	D+	56/100	—	—	—	-3.24%	$2.7M	Benchmark Subject
OCG Oriental Culture Holding LTD	D+	53/100	—	85.7%	-9.4%	+1.88%	$3.2M	/ocg-vs-mrm →
PMAX Powell Max Limited (Class A)	D+	57/100	—	—	—	-0.31%	$2.1M	/pmax-vs-mrm →
EJH E-Home Household Service Holdings Limited	E	33/100	—	22.4%	—	-3.65%	$4.2M	/ejh-vs-mrm →
JWEL Jowell Global Ltd.	D	50/100	—	—	-35.0%	+1.90%	$5.1M	/jwel-vs-mrm →

2. MRM Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

MEDIROM Healthcare Technologies Inc. (MRM) operates in Other Consumer Services (Consumer Discretionary) with an equity capitalization of $2.7M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. MRM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MRM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $0.35 (-3.24% 1D, market cap $2.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, MRM ranks #528 in composite RQD confidence.

How does MRM compare to OCG and PMAX in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Other Consumer Services), MRM carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, OCG (Oriental Culture Holding LTD) holds a D+ grade (53/100 RQD, P/E N/A, ROIC -9.4%, cap $3.2M) and PMAX (Powell Max Limited (Class A)) posts a D+ grade (57/100 RQD, P/E N/A, ROIC —, cap $2.1M). Among the 5-stock peer group, MRM leads on earnings multiple (N/A) while OCG leads on capital efficiency (-9.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MRM?

For MEDIROM Healthcare Technologies Inc. (MRM), key quantitative strengths include Established market leader in Consumer Discretionary with deep daily trading liquidity. and sector rank #528 in Consumer Discretionary, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MRM trading relative to its 50-day, 200-day, and 52-week technical levels?

MRM last traded at $0.35 (-3.24% on volume of 16,328 shares), positioning the stock -46.97% below its 50-day simple moving average ($0.66) and -66.67% below its 200-day simple moving average ($1.05). Across its 52-week range of $0.25 to $2.33, MRM sits at the 4.8% percentile with a 14-day RSI of 23.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.39).